Real-time enrollment status for this interstitial lung disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT06572384 |
| Recruiting Status | Recruiting |
| Condition | Interstitial Lung Disease |
| Phase | Clinical Trial |
| Target Enrollment | 440 participants |
| Active Locations | 16 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | January 27, 2026 (Jan 27, 2026) |
As of March 2, 2026: Clinical trial NCT06572384 is currently recruiting participants. This clinical trial study for interstitial lung disease is actively seeking new participants at 16 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06572384 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06572384 was last updated Jan 27, 2026 (January 27, 2026). HelloStudys verifies this status automatically.